布里瓦拉塞坦口服溶液的口味掩饰机制使用环氧和碳甲基纤维素
Conghui Li1, Junlin Yuan2, Hui Zhang2
1Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Beijing 100850, China; Institute of Health Service and Transfusion Medicine, Beijing 100850, China.
International journal of pharmaceutics
|March 5, 2025
概括
开发一种可口味的口服溶液用于抗药物布里瓦拉,涉及口味掩饰策略. 分子模拟揭示了减少布里瓦拉的关键辅助物相互作用.
科学领域:
- 制药科学 制药科学
- 药用化学 医学化学
- 计算化学的计算化学
背景情况:
- 布里瓦拉是一种用于小儿的新型抗药物.
- 口服溶液最好用于儿科的使用.
- 布里瓦拉塞坦的苦味需要口味掩饰以获得口感.
研究的目的:
- 为了开发一个美味的布里瓦拉塞坦口服溶液.
- 为了研究布里瓦拉和关键辅助剂 (碳甲基纤维素和2-Hydroxypropyl-β-cyclodextrin) 之间的相互作用.
- 在优化配方中阐明口味掩饰的机制.
主要方法:
- 对各种口味掩饰技术的选.
- 分子动力学模拟用于研究药物辅助剂相互作用.
- 分子对接来评估与苦味受体的结合亲和力.
主要成果:
- 成功制备了一种可口的布里瓦拉塞坦口服溶液.
- 布里瓦拉不封装在2-Hydroxypropyl-β-cyclodextrin中,而是通过键和π堆叠形成关联,由碳素甲基纤维素促进.
- 该配方通过减少布里瓦拉对苦味受体的结合,有效地掩盖了苦味.
结论:
- 通过了解药物辅助剂相互作用,可以实现布里瓦拉在口服溶液中的口味掩饰.
- 该研究提供了对制药应用的味道掩饰机制的见解.
- 这项工作有助于开发更易于食用的儿科药物.
相关概念视频
Masking and Demasking Agents
2.3K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
2.3K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
3.4K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
3.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
209
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
209
Drug Absorption Mechanism: Passive Membrane Transport
3.5K
Passive transport is a method of drug absorption where small, lipid-soluble drugs can move across the cell membrane. This movement happens along the concentration gradient, which is a natural flow from higher to lower concentration areas. The speed at which the drug moves is directly related to its lipid–water partition coefficient. This means that the more a drug dissolves in lipids, the faster it diffuses or spreads throughout the body. It is important to note that most drugs are either...
3.5K
Drug Delivery: Enteral Route
365
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
365
Racemic Mixtures and the Resolution of Enantiomers
18.0K
A racemic mixture, or racemate, is an equimolar mixture of enantiomers of a molecule that can be separated using their unique interaction with chiral molecules or media. Racemic mixtures are denoted by the (±)- prefix. This ‘optical rotation descriptor’ applies to the whole solution of a racemic mixture rather than a specific stereoisomer. Enantiomers typically have the same physical and chemical properties. Hence, they are not easily separable. However, enantiomers can exhibit...
18.0K


